Meeder Asset Management Lowered By $396,942 Its Rlj Lodging Trust (RLJ) Position; Mirati Therapeutics (MRTX) Sentiment Is 1.17

Mirati Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of oncology products. The company has market cap of $509.48 million. The companyÂ’s clinical stage product candidates include glesatinib, an orally-bioavailable, potent, small molecule kinase inhibitor that is in Phase II clinical trials for the treatment of non-small cell lung cancer patients with genetic alterations of MET; and in Phase Ib clinical trials in patients with genetic alterations of MET and Axl in NSCLC and other solid tumors. It currently has negative earnings. The Company’s clinical stage product candidates also comprise sitravatinib, an orally-bioavailable, potent, small molecule spectrum-selective kinase inhibitor, which is in Phase II clinical trials for the treatment of solid tumors, such as NSCLC and metastatic Renal Cell Carcinoma, as well as in Phase Ib clinical trials to treat NSCLC patients with RET, CHR4q12, CBL, and AXL genetic alterations; and mocetinostat, an orally administered spectrum-selective Class 1 histone deacetylase inhibitor, which is in Phase Ib/II clinical trials in combination with durvalumab for the treatment of patients with NSCLC.

Meeder Asset Management Inc decreased Rlj Lodging Trust (RLJ) stake by 95.14% reported in 2017Q3 SEC filing. Meeder Asset Management Inc sold 18,902 shares as Rlj Lodging Trust (RLJ)’s stock declined 12.57%. The Meeder Asset Management Inc holds 966 shares with $21,000 value, down from 19,868 last quarter. Rlj Lodging Trust now has $3.84B valuation. The stock decreased 1.96% or $0.44 during the last trading session, reaching $21.97. About 1.19 million shares traded. RLJ Lodging Trust (NYSE:RLJ) has risen 6.15% since December 30, 2016 and is uptrending. It has underperformed by 10.55% the S&P500.

Since September 5, 2017, it had 0 insider buys, and 1 sale for $201,100 activity. 10,000 shares were sold by DAVIS NATHANIEL A, worth $201,100.

Investors sentiment increased to 2.43 in Q3 2017. Its up 0.54, from 1.89 in 2017Q2. It is positive, as 19 investors sold RLJ shares while 42 reduced holdings. 53 funds opened positions while 95 raised stakes. 162.99 million shares or 29.18% more from 126.18 million shares in 2017Q2 were reported. Ameriprise Financial reported 401,637 shares. Dimensional Fund Advisors Limited Partnership invested in 2.61 million shares. Millennium Ltd Liability holds 123,381 shares. Renaissance Techs Ltd Liability invested 0.02% in RLJ Lodging Trust (NYSE:RLJ). Anchor Cap Advsr Limited Liability holds 17,562 shares or 0.01% of its portfolio. Bnp Paribas Asset holds 0.27% or 1.43M shares. 6,125 are held by James Inv Rech. New Mexico Educational Retirement Board reported 0.03% in RLJ Lodging Trust (NYSE:RLJ). 28,247 were reported by Shell Asset. 25,429 were reported by Dean Inv Assoc Lc. Hexavest holds 4,243 shares. State Bank Of Ny Mellon Corporation holds 0.01% or 1.41 million shares. Nine Chapters Capital Limited Liability reported 0.62% stake. 584,540 were reported by Lsv Asset Mgmt. Nationwide Fund Advsrs invested 0.02% in RLJ Lodging Trust (NYSE:RLJ).

Analysts await RLJ Lodging Trust (NYSE:RLJ) to report earnings on February, 28. They expect $0.51 EPS, down 15.00% or $0.09 from last year’s $0.6 per share. RLJ’s profit will be $89.19M for 10.77 P/E if the $0.51 EPS becomes a reality. After $0.61 actual EPS reported by RLJ Lodging Trust for the previous quarter, Wall Street now forecasts -16.39% negative EPS growth.

Meeder Asset Management Inc increased Charter Communications Inc stake by 6,257 shares to 6,573 valued at $2.39 million in 2017Q3. It also upped Bioverativ Inc stake by 5,414 shares and now owns 15,392 shares. Aetna Inc (NYSE:AET) was raised too.

Among 18 analysts covering RLJ Lodging Trust (NYSE:RLJ), 9 have Buy rating, 2 Sell and 7 Hold. Therefore 50% are positive. RLJ Lodging Trust had 47 analyst reports since August 7, 2015 according to SRatingsIntel. The rating was maintained by RBC Capital Markets with “Buy” on Thursday, August 3. The stock has “Sell” rating by Ladenburg Thalmann on Tuesday, January 19. KeyBanc Capital Markets maintained the stock with “Hold” rating in Monday, October 23 report. The stock has “Buy” rating by RBC Capital Markets on Friday, June 23. The firm earned “Outperform” rating on Wednesday, March 23 by Credit Suisse. The rating was reinitiated by Barclays Capital on Friday, October 6 with “Equal Weight”. The firm has “Hold” rating given on Tuesday, December 19 by Robert W. Baird. The stock has “Hold” rating by KeyBanc Capital Markets on Friday, September 22. The stock of RLJ Lodging Trust (NYSE:RLJ) earned “Underweight” rating by Barclays Capital on Wednesday, March 9. The stock has “Outperform” rating by RBC Capital Markets on Monday, January 4.

The stock decreased 3.18% or $0.6 during the last trading session, reaching $18.25. About 339,585 shares traded. Mirati Therapeutics, Inc. (MRTX) has declined 76.51% since December 30, 2016 and is downtrending. It has underperformed by 93.21% the S&P500.

Analysts await Mirati Therapeutics, Inc. (NASDAQ:MRTX) to report earnings on March, 8. They expect $-0.65 EPS, up 34.34% or $0.34 from last year’s $-0.99 per share. After $-0.65 actual EPS reported by Mirati Therapeutics, Inc. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

The post Meeder Asset Management Lowered By $396,942 Its Rlj Lodging Trust (RLJ) Position; Mirati Therapeutics (MRTX) Sentiment Is 1.17 appeared first on Stock Market News | HillCountryTimes | Get it Today.

from
https://www.hillcountrytimes.com/2017/12/30/meeder-asset-management-lowered-by-396942-its-rlj-lodging-trust-rlj-position-mirati-therapeutics-mrtx-sentiment-is-1-17/